Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Novocure Ltd Ord Sh (NVCR)
Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,832,509
  • Shares Outstanding, K 106,209
  • Annual Sales, $ 537,840 K
  • Annual Income, $ -92,530 K
  • 60-Month Beta 0.80
  • Price/Sales 9.61
  • Price/Cash Flow N/A
  • Price/Book 11.55
Trade NVCR with:

Options Overview Details

View History
  • Implied Volatility 84.60% ( unch)
  • Historical Volatility 168.55%
  • IV Percentile 76%
  • IV Rank 13.42%
  • IV High 293.95% on 01/04/23
  • IV Low 52.16% on 03/02/23
  • Put/Call Vol Ratio 1.22
  • Today's Volume 643
  • Volume Avg (30-Day) 3,625
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 63,918
  • Open Int (30-Day) 47,328

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.46
  • Number of Estimates 5
  • High Estimate -0.42
  • Low Estimate -0.53
  • Prior Year -0.23
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.53 +1.29%
on 06/08/23
83.60 -48.47%
on 05/16/23
-26.94 (-38.47%)
since 05/09/23
3-Month
42.53 +1.29%
on 06/08/23
83.60 -48.47%
on 05/16/23
-27.62 (-39.07%)
since 03/09/23
52-Week
42.53 +1.29%
on 06/08/23
120.03 -64.11%
on 01/05/23
-28.42 (-39.75%)
since 06/09/22

Most Recent Stories

More News
Markets Today: Stocks Slightly Higher on Strength in Tesla and Netflix

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are up +0.09%, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.11%. U.S. stock index futures this morning are slightly higher. Tesla...

ESM23 : 4,315.00 (+0.39%)
NQM23 : 14,585.75 (+0.57%)
TSLA : 249.77 (+6.35%)
NFLX : 417.15 (+1.90%)
PLAY : 37.98 (-1.02%)
AMZN : 124.48 (+0.19%)
YEXT : 12.98 (-4.91%)
SMCI : 264.83 (+4.12%)
NVCR : 42.84 (-5.85%)
CASY : 219.41 (-0.18%)
BASE : 16.43 (+4.25%)
UNFI : 20.77 (-5.16%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NovoCure Limited ("NovoCure" or the "Company") (NASDAQ: NVCR). Such investors...

NVCR : 42.84 (-5.85%)
These 2 Nasdaq Stocks Are Plunging. Here's Why

Tuesday brought optimism to the stock market overall, but not for these companies.

COMP : 3.70 (+0.82%)
$NASX : 13,299.89 (+0.46%)
NVCR : 42.84 (-5.85%)
COIN : 54.66 (-0.44%)
Why NovoCure Stock Is Crashing Today

Analysts weren't wowed by the company's late-stage data.

NVCR : 42.84 (-5.85%)
3 No-Brainer Stocks to Buy for Under $100 Right Now

These stocks might not remain under $100 for too much longer.

CRSP : 61.64 (-1.52%)
NVCR : 42.84 (-5.85%)
PFE : 39.30 (+0.54%)
Stocks Undercut as Little Progress is seen in U.S. Debt Ceiling Talks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.01%, and the Nasdaq 100 Index ($IU ) (QQQ ) closed up...

$SPX : 4,311.36 (+0.41%)
SPY : 431.55 (+0.56%)
$DOWI : 33,931.72 (+0.29%)
DIA : 340.01 (+0.35%)
$IUXX : 14,566.41 (+0.57%)
QQQ : 356.31 (+0.89%)
HD : 298.32 (-0.92%)
CZR : 48.70 (+0.31%)
ETSY : 92.61 (+5.77%)
MHK : 96.09 (-1.95%)
WHR : 142.74 (-0.82%)
SGEN : 195.84 (+0.58%)
Stocks Mixed as Debt Ceiling Talks Resume

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.16%. U.S....

$SPX : 4,311.36 (+0.41%)
SPY : 431.55 (+0.56%)
$DOWI : 33,931.72 (+0.29%)
DIA : 340.01 (+0.35%)
$IUXX : 14,566.41 (+0.57%)
QQQ : 356.31 (+0.89%)
HD : 298.32 (-0.92%)
MHK : 96.09 (-1.95%)
MAS : 54.36 (-0.53%)
SWK : 85.31 (-1.18%)
WHR : 142.74 (-0.82%)
SGEN : 195.84 (+0.58%)
Markets Today: Stocks Slip Ahead of U.S. Debt Ceiling Talks

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are down -0.26%, and June Nasdaq 100 E-Mini futures (NQM2 3) are down -0.21%. U.S. stock index futures this morning are moderately lower...

ESM23 : 4,315.00 (+0.39%)
NQM23 : 14,585.75 (+0.57%)
HD : 298.32 (-0.92%)
HZNP : 99.39 (-0.03%)
RUM : 10.01 (+1.01%)
FWRG : 16.75 (-5.21%)
RH : 265.60 (+0.48%)
DCO : 45.44 (-0.63%)
COF : 111.44 (-0.17%)
BEEM : 10.97 (-4.28%)
GILD : 78.16 (-0.31%)
NVCR : 42.84 (-5.85%)
Should You Buy Novocure Stock Right Now?

Most Wall Street analysts think this stock will skyrocket. They could be right.

NVCR : 42.84 (-5.85%)
NovoCure (NVCR) Q1 2023 Earnings Call Transcript

NVCR earnings call for the period ending March 31, 2023.

NVCR : 42.84 (-5.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.

See More

Key Turning Points

3rd Resistance Point 54.16
2nd Resistance Point 51.24
1st Resistance Point 48.37
Last Price 42.84
1st Support Level 42.58
2nd Support Level 39.66
3rd Support Level 36.79

See More

52-Week High 120.03
Fibonacci 61.8% 90.42
Fibonacci 50% 81.28
Fibonacci 38.2% 72.13
Last Price 42.84
52-Week Low 42.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar